C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.

Saved in:
Bibliographic Details
Title: C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.
Authors: Bonazzi, Vanessa F.1 (AUTHOR) v.bonazzi@uq.edu.au, Aoude, Lauren G.1 (AUTHOR), Brosda, Sandra1 (AUTHOR), Bradford, Julia J.1 (AUTHOR), Lonie, James M.1 (AUTHOR), Loffler, Kelly A.1,2 (AUTHOR), Gartside, Michael G.1 (AUTHOR), Patel, Kalpana1 (AUTHOR), Mukhopadhyay, Pamela3 (AUTHOR), Keane, Colm4 (AUTHOR), Gebski, Val5 (AUTHOR), Kench, James G.6,7 (AUTHOR), Goldstein, David8 (AUTHOR), Waddell, Nicola3 (AUTHOR), Barbour, Andrew P.1,9 (AUTHOR)
Source: Asia Pacific Journal of Clinical Oncology. Feb2025, Vol. 21 Issue 1, p77-86. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17437555
DOI:10.1111/ajco.13993